Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings

• Jillian SY. Lau,
• Thomas A. Rasmussen,
• Sharon R. Lewin,
• Adam Ehm,
• Cipriano Martinez,
• Craig Burnett,
• James H. McMahon

Affiliations

Jillian SY. Lau

Corresponding author. Department of Infectious Diseases, The Alfred Hospital, 85 Commercial Road, Prahran, 3181, Victoria, Australia.; The Alfred Hospital and Monash University, Victoria, Australia

Thomas A. Rasmussen

The Peter Doherty Institute for Infection and Immunity, And the University of Melbourne, Victoria, Australia

Sharon R. Lewin

The Alfred Hospital and Monash University, Victoria, Australia; The Peter Doherty Institute for Infection and Immunity, And the University of Melbourne, Victoria, Australia

Adam Ehm

Melbourne HIV Cure Consortium Community Advisory Board, Living Positive Victoria, Australia

Cipriano Martinez

National Association of People Living with HIV Australia, New South Wales, Australia

Craig Burnett

Melbourne HIV Cure Consortium Community Advisory Board, Living Positive Victoria, Australia

James H. McMahon

The Alfred Hospital and Monash University, Victoria, Australia; Monash Medical Centre, Victoria, Australia